Pacira Pharmaceuticals buy Needham & Company LLC
Start price
08.05.24
/
50%
€26.60
Target price
08.05.25
€39.99
Performance (%)
3.76%
Price
04.06.24
€27.80
Summary
This prediction is currently active. With a performance of 3.76%, the BUY prediction by Needham___Company_LL for Pacira Pharmaceuticals is trending in the right direction. This prediction currently runs until 08.05.25. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Pacira Pharmaceuticals | 0.000% |
iShares Core DAX® | -1.042% |
iShares Nasdaq 100 | -1.361% |
iShares Nikkei 225® | -0.044% |
iShares S&P 500 | -0.480% |
Comments by Needham___Company_LL for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its price target lowered by analysts at Needham & Company LLC from $45.00 to $43.00. They now have a "buy" rating on the stock.
Ratings data for PCRX provided by MarketBeat
Stopped prediction by Needham___Company_LL for Pacira Pharmaceuticals
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€25.80
09.04.24
09.04.24
€41.35
09.04.25
09.04.25
6.98%
04.06.24
04.06.24
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€26.80
01.03.24
01.03.24
€41.61
01.03.25
01.03.25
2.99%
04.06.24
04.06.24
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€33.40
03.08.23
03.08.23
€47.53
03.08.24
03.08.24
-17.37%
04.06.24
04.06.24
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€41.00
20.04.23
20.04.23
€54.71
20.04.24
20.04.24
-40.98%
21.04.24
21.04.24
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€40.40
28.02.23
28.02.23
€56.63
28.02.24
28.02.24
-32.18%
29.02.24
29.02.24